KM

Keith Manchester

Director at Kriya Therapeutics

Keith Manchester is a partner and the Head of Life Sciences for QVT Family Office (f/k/a QVT Financial LP), an asset management company, where he has been employed since 2005. Dr. Manchester focuses on investments in both publicly traded and privately owned life sciences companies. Prior to joining QVT, Dr. Manchester was Vice President of Business Development from 2002 to 2004 and Director of Business Development from 2000 to 2002 at Applied Molecular Evolution, Inc., a biotechnology company. From 1999 to 2000, Dr. Manchester was an Associate at Vestar Capital Partners, a private equity firm. From 1997 to 1999, Dr. Manchester was an investment banker in the healthcare group at Goldman, Sachs & Co. Dr. Manchester received his A.B. degree from Harvard College and his M.D. degree from Harvard Medical School. Dr. Manchester serves as a director for the following companies: Roivant Sciences Ltd, Roivant Sciences, Inc., and Arbutus Biopharma Corporation. Dr. Manchester also sits on the Supervisory Board of Medigene AG.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Kriya Therapeutics

2 followers

Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs.


Employees

11-50

Links